Due to its rapid development of resistance to nearly all arrays of acaricide, Tetranychus urticae is extremely hard to control using conventional acaricides. As an alternative control measure of acaricide-resistant mites, RNA interference (RNAi)-based methods have recently been suggested. A double-stranded RNA (dsRNA) delivery method using multi-unit chambers was established and employed to screen the RNAi toxicity of 42 T. urticae genes. Among them, the dsRNA treatment of coatomer I (COPI) genes, such as coatomer subunit epsilon (COPE) and beta 2 (COPB2), resulted in high mortality [median lethal time (LT50) = 89.7 and 120.3h, respectively]. The transcript level of the COPE gene was significantly (F3,9 = 16.2, P =0.001) reduced by up to 24% following dsRNA treatment, suggesting that the toxicity was likely mediated by the RNAi of the target gene. As a toxicity enhancement strategy, the recombinant dsRNA was generated by reciprocally recombining half-divided fragments of COPE and COPB2. The two recombinant dsRNAs exhibited higher toxicity than the respective single dsRNA treatments as determined using LT50 values (79.2 and 81.5h, respectively). This finding indicates that the recombination of different genes can enhance RNAi toxicity and be utilized to generate synthetic dsRNA with improved RNAi efficacy.

비티 포자와 Xenorhabdus nematophila (Xn)의 배양액을 혼합하여 비티플러스가 개발되었다. 높은 살충력에도 불구하고 비티플러스는 다 양한 해충에 대한 넓은 살충범위를 보이지 않는 한계가 있다. 본 연구에서는 Xn 대사물질 첨가를 통한 파밤나방과 같은 비감수성 해충에 대한 비 티플러스의 살충력 향상에 초점을 맞추었다. Xn의 주요 대사물질인 oxindole (OI)과 benzylideneacetone (BZA)는 비티의 살충력을 향상시킨 다고 보고되었다. 본 연구에서 OI 또는 BZA의 첨가는 비티플러스의 살충력을 향상시켰다. 그러나 동결건조된 Xn 배양액의 첨가는 보다 낮은 농 도의 OI 또는 BZA로도 충분히 비피플러스의 살충력을 상승시켰다. HPLC 분석에서 Xn 배양액에 최소 12개의 대사물질이 포함되어 있는 것을 확인하였다. 이러한 결과는 OI와 BZA 외에도 Xn 대사물질에 생리활성물질이 존재하는 것을 제시한다.

Double-stranded RNA(dsRNA) had been used to specitically suppress target gene expression at post-tanscription level. Injection of dsRNA to hemocoel is the most efficient to knockdown target mRNA. However, some insects have shown to be susceptible to feeding dsRNA. Spodoptera exigua was susceptible to dsRNA at oral treatment. Especially dsRNA specific to β-integrin was potent to survival of S.exigua larvae. This study advanced our dsRNA application technology by generating recombinant E.coli expressing dsRNA specific the β-integrin. A recombinant vector L4440 was constructed with a partial β-integrin gene under T7 RNA polymerase promoter. The recombinant vector was used to transform HT115 competent cells of E.coli. The transformed E.coli expressed the dsRNA. The production of dsRNA was proportional to the bacterial number. By feeding the recombinant E.coli, S.exigua underwent significant mortality. By adding E.coli expressing Cry1Ca Bt toxin to E.coli expressing dsRNA, S.exigua exhibited highly enhanced mortality. This study suggests a possibility to use a recombinant E.coli expressing dsRNA to control S.exigua.